España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
NeoGenomics
NEO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$15.04
-0.75
-4.75%
At close: -
$15.55
0.51
3.39%
After Hours: 5:50 PM EDT
Get Report
Comment
NeoGenomics (NEO) Forecast
News
Earnings
NeoGenomics (NEO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for NeoGenomics (NASDAQ:NEO) Stock
NeoGenomics Stock (NASDAQ: NEO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 06, 2024
Needham Reiterates Buy on NeoGenomics, Mainta...
Benzinga Newsdesk
Tuesday, November 05, 2024
NeoGenomics Reiterates FY24 Revenue Outlook I...
Benzinga Newsdesk
NeoGenomics Q3 2024 Adj. EPS $0.05 Beats $0.0...
Benzinga Newsdesk
Tuesday, October 22, 2024
NeoGenomics Gains New York State Approval For...
Benzinga Newsdesk
Wednesday, September 25, 2024
Needham Reiterates Buy on NeoGenomics, Mainta...
Benzinga Newsdesk
Tuesday, September 24, 2024
Expert Ratings For NeoGenomics
Benzinga Insights
Benchmark Reiterates Buy on NeoGenomics, Main...
Benzinga Newsdesk
Monday, September 23, 2024
Court Orders Permanent Injunction Against Neo...
Benzinga Newsdesk
Wednesday, September 11, 2024
NeoGenomics To Present New Data Highlighting ...
Benzinga Newsdesk
Monday, August 05, 2024
Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
Lekha Gupta
Tuesday, July 30, 2024
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
NeoGenomics shares are trading higher after t...
Benzinga Newsdesk
Stephens & Co. Reiterates Overweight on NeoGe...
Benzinga Newsdesk
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Benchmark Reiterates Buy on NeoGenomics, Main...
Benzinga Newsdesk
Needham Reiterates Buy on NeoGenomics, Mainta...
Benzinga Newsdesk
Monday, July 29, 2024
NeoGenomics Raises FY24 Consolidated Revenue ...
Benzinga Newsdesk
NeoGenomics Q2 2024 Adj. EPS $0.03 Beats $0.0...
Benzinga Newsdesk
Tuesday, May 28, 2024
NeoGenomics Introduces Comprehensive Lung Sol...
Benzinga Newsdesk
Friday, May 10, 2024
NeoGenomics Earnings Analysis: Q1 Recap
Benzinga Insights
Thursday, May 02, 2024
BTIG Maintains Buy on NeoGenomics, Lowers Pri...
Benzinga Newsdesk
Wednesday, May 01, 2024
TD Cowen Maintains Buy on NeoGenomics, Lowers...
Benzinga Newsdesk
Craig-Hallum Assumes NeoGenomics at Buy, Anno...
Benzinga Newsdesk
Benchmark Reiterates Buy on NeoGenomics, Main...
Benzinga Newsdesk
Tuesday, April 30, 2024
Where NeoGenomics Stands With Analysts
Benzinga Insights
Needham Maintains Buy on NeoGenomics, Lowers ...
Benzinga Newsdesk
NeoGenomics shares are trading lower. The com...
Benzinga Newsdesk
CORRECTION: NeoGenomics Ticker Is NEO
Benzinga Newsdesk
NeoGenomics Sees Fy24 Revenue Of $650M - $660...
Benzinga Newsdesk
NeoGenomics Q1 Adj $(0.02) Beats $(0.05) Esti...
Benzinga Newsdesk
Monday, March 18, 2024
What 6 Analyst Ratings Have To Say About NeoGenomics
Benzinga Insights
Friday, March 15, 2024
Earnings Scheduled For March 15, 2024
Benzinga Insights
Monday, February 26, 2024
Piper Sandler Maintains Overweight on NeoGeno...
Benzinga Newsdesk
Thursday, February 22, 2024
Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
Benzinga Insights
Wednesday, February 21, 2024
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
Vandana Singh
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
NeoGenomics shares are trading higher after t...
Benzinga Newsdesk
Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Evaluating NeoGenomics: Insights From 4 Financial Analysts
Benzinga Insights
Needham Maintains Buy on NeoGenomics, Raises ...
Benzinga Newsdesk
Tuesday, February 20, 2024
NeoGenomics shares are trading higher after t...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
NeoGenomics Sees FY24 Adj. EPS $0.04 Vs $(0.0...
Benzinga Newsdesk
Recap: NeoGenomics Q4 Earnings
Benzinga Insights
NeoGenomics Q4 2023 Adj EPS $0.03 Beats $(0.0...
Benzinga Newsdesk
Earnings Scheduled For February 20, 2024
Benzinga Insights
Monday, February 19, 2024
NeoGenomics's Earnings Outlook
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch